PTC To Fight EMA Translarna No, Novartis Considers Revolade Next Steps

 
• By Maureen Kenny

PTC Therapeutics and Novartis are working on their next steps after the European Medicines Agency recommended against approving their requests to expand the indication of their respective products in the EU.

Thumb
PTC will ask the CHMP to re-examine why it rejected its application. • Source: Shutterstock

More from Archive

More from Pink Sheet